A detailed history of Armistice Capital, LLC transactions in Eyenovia, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 6,060,606 shares of EYEN stock, worth $3.39 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
6,060,606
Holding current value
$3.39 Million
% of portfolio
0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.52 - $1.06 $3.15 Million - $6.42 Million
6,060,606 New
6,060,606 $3.58 Million
Q4 2023

Feb 13, 2024

BUY
$1.08 - $2.08 $1.39 Million - $2.69 Million
1,290,979 Added 41.82%
4,378,000 $9.11 Million
Q3 2023

Nov 14, 2023

BUY
$1.57 - $2.54 $4.85 Million - $7.84 Million
3,087,021 New
3,087,021 $5.12 Million
Q2 2022

Aug 15, 2022

SELL
$1.71 - $3.26 $619,635 - $1.18 Million
-362,360 Reduced 15.78%
1,934,261 $3.77 Million
Q1 2022

May 16, 2022

BUY
$2.66 - $3.99 $6.11 Million - $9.16 Million
2,296,621 New
2,296,621 $7.01 Million

Others Institutions Holding EYEN

About EYENOVIA, INC.


  • Ticker EYEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,212,900
  • Market Cap $19.2M
  • Description
  • Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...
More about EYEN
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.